✦ LIBER ✦

Adoptive Immunotherapy by Allogeneic Stem Cell Transplantation for Metastatic Renal Cell Carcinoma: A CALGB Intergroup Phase II Study

✍ Scribed by Brian I. Rini; Susan Halabi; Robert Barrier; Kim A. Margolin; David Avigan; Theodore Logan; Walter M. Stadler; Philip L. McCarthy; Charles A. Linker; Eric J. Small

Book ID: 116279014
Publisher: Elsevier Science
Year: 2006
Tongue: English
Weight: 133 KB
Volume: 12
Category: Article
ISSN: 1083-8791
DOI: 10.1016/j.bbmt.2006.03.011

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase II study of constant-infusion fl

A phase II study of constant-infusion floxuridine for the treatment of metastatic renal cell carcinoma

✍ Mary J. Wilkinson; John W. Frye; Eric J. Small; Alan P. Venook; Peter R. Carroll 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 347 KB 👁 2 views

Background. Twenty-nine patients with metastatic renal cell carcinoma (RCC) were treated with constantinfusion floxuridine (FUdR, Roche Laboratories, Nut-Methods. The initial dosage was 0.075 mg/kg/day for 14 days every 28 days and was increased or decreased by 0.025-mg/kg/day increments at each sub

Modulation of human lymphoblastoid inter

Modulation of human lymphoblastoid interferon activity by melatonin in metastatic renal cell carcinoma. A phase II study

✍ Bruno Neri; Carlo Fiorelli; Fausto Moroni; Giulio Nicita; Maria Cristina Paolett 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 449 KB 👁 3 views

PO-53 Phase II study of low molecular we

PO-53 Phase II study of low molecular weight heparin (LMWH) in combination with immunotherapy in metastatic renal cell carcinoma patients

✍ I. Tsimafeyeu; A. Madzhuga; L. Demidov; O. Somonova; A. Yelizarova 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 51 KB

Phase II study of dose-modified busulfan

Phase II study of dose-modified busulfan by real-time targeting in allogeneic hematopoietic stem cell transplantation for myeloid malignancy

✍ Yachiyo Kuwatsuka; Akio Kohno; Seitaro Terakura; Shigeki Saito; Kazuyuki Shimada 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 303 KB

Allogeneic hematopoietic stem cell trans

Allogeneic hematopoietic stem cell transplantation with a reduced-intensity conditioning regimen for treatment of metastatic renal cell carcinoma: single institution experience with a minimum 1-year follow-up

✍ Tohru Nakagawa; Masahiro Kami; Akiko Hori; Sung-Won Kim; Naoko Murashige; Tamae 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 216 KB

Immunochemotherapy with interleukin-2, i

Immunochemotherapy with interleukin-2, interferon- α and 5-fluorouracil for progressive metastatic renal cell carcinoma: a multicenter phase II study

✍ Herpen, C.M.L.v. 📂 Article 📅 2000 🏛 Nature Publishing Group 🌐 English ⚖ 70 KB